These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth]. Cambier J; Dairou R Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144 [No Abstract] [Full Text] [Related]
12. [Encephalopathy caused by ingestion of bismuth salts]. Aerts J Arch Belg Med Soc; 1976 Oct; 34(8):517-25. PubMed ID: 1028385 [No Abstract] [Full Text] [Related]
14. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol]. Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373 [TBL] [Abstract][Full Text] [Related]
15. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment]. Buge A; Rancurel G; Poisson M; Dechy H Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313 [No Abstract] [Full Text] [Related]
16. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)]. Eichler I Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997 [TBL] [Abstract][Full Text] [Related]
17. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology]. Olive G Therapie; 1980; 35(3):305-6. PubMed ID: 6775384 [No Abstract] [Full Text] [Related]
18. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment]. Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823 [No Abstract] [Full Text] [Related]